Bio Protocol to Launch First BioAgent Sale Project Aubrai, with 20% of Total Supply Allocated for Sale
Foresight News reports that the decentralized science (DeSci) platform Bio Protocol will launch its first BioAgent sale project, Aubrai. Aubrai has a total supply of 2 million tokens, of which 20% will be allocated for sale, 6% for the liquidity pool, 15% for the treasury, 20.1% for initial backers, 10% for LEVF, 22% for VitaDAO, and 6.9% for Bio Protocol. The token TGE is scheduled for August 25.
Aubrai is a decentralized scientific agent jointly developed by VitaDAO and BIO, aimed at combating human aging.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WLFI Now Available on Hyperliquid Pre-Launch Contracts
A major whale transferred 77,736 ETH to an exchange 10 minutes ago
XRP market capitalization surpasses $180 billion, overtaking Pinduoduo
Publicly Listed AMTD Group Plans to Include BTC, ETH, and USDT in Its Investment Portfolio
Trending news
MoreCrypto prices
More
